Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Illumina, Inc. ILMN

Healthcare  —  Diagnostics & Research
270.00 (3.90) (1.42%) as of 25 Sep
Market cap
$41.3B
P/E
50.4×
S&P 500 Member Cash Flow Champion (3y) Insider Buys (last 12m)
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Illumina, Inc. (ILMN) Price to free cash flow

As of 25 September 2026, Illumina, Inc. (ILMN) trades at a price to free cash flow of 44.9×. Over the past ten years it has ranged from 0.0× (September 2023) to 868× (August 2022); the current reading is higher than 34% of that period. That is above the Diagnostics & Research industry median of 34.0× and above the Healthcare sector median of 19.5×.

Price to free cash flow, daily

Annual

Period Price to free cash flow Change
FY2025 22.2× (26.15%)
FY2024 30.1× (60.07%)
FY2023 75.3× —
FY2022 0.0× —
FY2021 171× 184.32%
FY2020 60.3× 5.31%
FY2019 57.2× 11.14%
FY2018 51.5× (10.68%)
FY2017 57.6× 56.07%
FY2016 36.9× (17.18%)

Quarterly

Period Price to free cash flow Change
Jun 2026 29.0× 47.39%
Mar 2026 19.7× (11.40%)
Dec 2025 22.2× 50.45%
Sep 2025 14.8× 0.06%
42 more quarters

Against its own ten years

Low 0.0× High 868×
Ten-year median 54.4×
Current reading's percentile 34

Price to free cash flow against peers

Company Price to free cash flow
GH Guardant Health, Inc. compare n/m
DGX Quest Diagnostics Incorporated compare 19.4×
IQV IQVIA Holdings Inc. compare 19.9×
IDXX IDEXX Laboratories, Inc. compare 33.1×
MTD Mettler-Toledo International, Inc. compare 35.2×
A Agilent Technologies, Inc. compare 38.4×
ILMN Illumina, Inc. 44.9×
WAT Waters Corporation compare 116×
NTRA Natera, Inc. compare 702×
Diagnostics & Research industry median 34.0×
Healthcare sector median 19.5×
Market median 14.0×

What Price to free cash flow is

Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.

Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))

The full definition of Price to free cash flow →

More on ILMN